Young-Sam Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Young-Sam Lee has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Sung Bae Lee
Department of Brain Sciences, DGIST, Daegu, Republic of Korea
6 shared publications Eun Jae Yang
Department of New Biology, DGIST, Daegu, Korea
5 shared publications- Sang Chul Park
The Future Life & Society Research Center, Advanced Institute of Aging Science, Chonnam National University, Gwangju 61469, Republic of Korea
5 shared publications - Daehee Hwang
School of Biological Sciences, Seoul National University, Seoul, Republic of Korea
4 shared publications Jeong-A Hwang
Department of New Biology, DGIST, Daegu, Korea
3 shared publications- Jinsoo Seo
Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea
3 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Springer Nature in Nature Communications
Failure of TSPO-dependent metabolic compensation marks the loss of mitochondrial bioenergetic adaptation in parkin-deficient neurons
Neurons require mitochondrial bioenergetic flexibility to withstand chronic mitochondrial quality control failure, yet the compensatory safeguards that preserve mitochondrial functional output during neurodegenerative progression remain unclear. Here, using parkin- deficient fly models, we identify an early mitochondrial metabolic signature characterized by reduced pyruvate and increased glutamate and α-ketoglutarate. Substrate-specific mitochondrial respiration and ATP assays showed impaired pyruvate-supported bioenergetic capacity but preserved glutamate-supported bioenergetic capacity, supporting a transient glutamate-linked compensatory state before neurodegenerative deterioration. We identify neuronal TSPO upregulation as an adaptive compensatory mechanism that sustains glutamate-supported mitochondrial bioenergetic capacity under parkin -deficient conditions. In human iPSC-derived neurons, parkin deficiency was similarly associated with TSPO upregulation, and TSPO modulation altered neuronal vulnerability. TSPO induction was controlled by JNK-Jun/Nrf2 signaling, whose age-associated attenuation compromised compensation and accelerated neurodegeneration. Thus, loss of TSPO-dependent glutamate-linked bioenergetic compensation marks the transition from mitochondrial adaptation to neurodegenerative deterioration under parkin -deficient conditions.
- 13 November 2026
- Published by Springer Nature in Nature Communications
Open AccessFailure of TSPO-dependent metabolic compensation marks the loss of mitochondrial bioenergetic adaptation in parkin-deficient neurons
Neurons require mitochondrial bioenergetic flexibility to withstand chronic mitochondrial quality control failure, yet the compensatory safeguards that preserve mitochondrial functional output during neurodegenerative progression remain unclear. Here, using parkin- deficient fly models, we identify an early mitochondrial metabolic signature characterized by reduced pyruvate and increased glutamate and α-ketoglutarate. Substrate-specific mitochondrial respiration and ATP assays showed impaired pyruvate-supported bioenergetic capacity but preserved glutamate-supported bioenergetic capacity, supporting a transient glutamate-linked compensatory state before neurodegenerative deterioration. We identify neuronal TSPO upregulation as an adaptive compensatory mechanism that sustains glutamate-supported mitochondrial bioenergetic capacity under parkin -deficient conditions. In human iPSC-derived neurons, parkin deficiency was similarly associated with TSPO upregulation, and TSPO modulation altered neuronal vulnerability. TSPO induction was controlled by JNK-Jun/Nrf2 signaling, whose age-associated attenuation compromised compensation and accelerated neurodegeneration. Thus, loss of TSPO-dependent glutamate-linked bioenergetic compensation marks the transition from mitochondrial adaptation to neurodegenerative deterioration under parkin -deficient conditions.
- Open Access
- 2 November 2026
- Published by Springer Nature in npj Aging
Nanomechanical profiling of cellular senescence and aging with advanced force probes and deep learning
Biological aging manifests as complex, systemic deterioration across tissues, yet conventional molecular biomarkers lack universality. Biophysical phenotyping offers an alternative, capturing the structural consequences of cellular senescence and matrix remodeling as functional readouts. This review explores advanced nanomechanical tools and the integrated mechanome framework. By leveraging deep learning to decode these multi-parametric physical signatures, we outline a translational roadmap for tracking physiological decline and evaluating therapeutic interventions.
- 2 November 2026
- Published by Springer Nature in npj Aging
Open AccessNanomechanical profiling of cellular senescence and aging with advanced force probes and deep learning
Biological aging manifests as complex, systemic deterioration across tissues, yet conventional molecular biomarkers lack universality. Biophysical phenotyping offers an alternative, capturing the structural consequences of cellular senescence and matrix remodeling as functional readouts. This review explores advanced nanomechanical tools and the integrated mechanome framework. By leveraging deep learning to decode these multi-parametric physical signatures, we outline a translational roadmap for tracking physiological decline and evaluating therapeutic interventions.
- Open Access
- 27 October 2026
- Published by Elsevier in Molecules and Cells
- Vol. 49 (12)
Updated guide to the assessment of mammalian cellular senescence
- 27 October 2026
- Published by Elsevier in Molecules and Cells
- Vol. 49 (12)
Open AccessUpdated guide to the assessment of mammalian cellular senescence
- 10 January 2024
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 24 (6) , 1882-1890
From Homogeneity to Turing Pattern: Kinetically Controlled Self-Organization of Transmembrane Protein
Understanding the spatial organization of membrane proteins is crucial for unraveling key principles in cell biology. The reaction-diffusion model is commonly used to understand biochemical patterning; however, applying reaction-diffusion models to subcellular phenomena is challenging because of the difficulty in measuring protein diffusivity and interaction kinetics in the living cell. In this work, we investigated the self-organization of the plasmalemma vesicle-associated protein (PLVAP), which creates regular arrangements of fenestrated ultrastructures, using single-molecule tracking. We demonstrated that the spatial organization of the ultrastructures is associated with a decrease in the association rate by actin destabilization. We also constructed a reaction-diffusion model that accurately generates a hexagonal array with the same 130 nm spacing as the actual scale and informs the stoichiometry of the ultrastructure, which can be discerned only through electron microscopy. Through this study, we integrated single-molecule experiments and reaction-diffusion modeling to surpass the limitations of static imaging tools and proposed emergent properties of the PLVAP ultrastructure.
- 10 January 2024
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 24 (6) , 1882-1890
From Homogeneity to Turing Pattern: Kinetically Controlled Self-Organization of Transmembrane Protein
Understanding the spatial organization of membrane proteins is crucial for unraveling key principles in cell biology. The reaction-diffusion model is commonly used to understand biochemical patterning; however, applying reaction-diffusion models to subcellular phenomena is challenging because of the difficulty in measuring protein diffusivity and interaction kinetics in the living cell. In this work, we investigated the self-organization of the plasmalemma vesicle-associated protein (PLVAP), which creates regular arrangements of fenestrated ultrastructures, using single-molecule tracking. We demonstrated that the spatial organization of the ultrastructures is associated with a decrease in the association rate by actin destabilization. We also constructed a reaction-diffusion model that accurately generates a hexagonal array with the same 130 nm spacing as the actual scale and informs the stoichiometry of the ultrastructure, which can be discerned only through electron microscopy. Through this study, we integrated single-molecule experiments and reaction-diffusion modeling to surpass the limitations of static imaging tools and proposed emergent properties of the PLVAP ultrastructure.
- Open Access
- 22 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Mid-old cells are a potential target for anti-aging interventions in the elderly
The biological process of aging is thought to result in part from accumulation of senescent cells in organs. However, the present study identified a subset of fibroblasts and smooth muscle cells which are the major constituents of organ stroma neither proliferative nor senescent in tissues of the elderly, which we termed “mid-old status” cells. Upregulation of pro-inflammatory genes (IL1B and SAA1) and downregulation of anti-inflammatory genes (SLIT2 and CXCL12) were detected in mid-old cells. In the stroma, SAA1 promotes development of the inflammatory microenvironment via upregulation of MMP9, which decreases the stability of epithelial cells present on the basement membrane, decreasing epithelial cell function. Remarkably, the microenvironmental change and the functional decline of mid-old cells could be reversed by a young cell-originated protein, SLIT2. Our data identify functional reversion of mid-old cells as a potential method to prevent or ameliorate aspects of aging-related tissue dysfunction.
- 22 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessMid-old cells are a potential target for anti-aging interventions in the elderly
The biological process of aging is thought to result in part from accumulation of senescent cells in organs. However, the present study identified a subset of fibroblasts and smooth muscle cells which are the major constituents of organ stroma neither proliferative nor senescent in tissues of the elderly, which we termed “mid-old status” cells. Upregulation of pro-inflammatory genes (IL1B and SAA1) and downregulation of anti-inflammatory genes (SLIT2 and CXCL12) were detected in mid-old cells. In the stroma, SAA1 promotes development of the inflammatory microenvironment via upregulation of MMP9, which decreases the stability of epithelial cells present on the basement membrane, decreasing epithelial cell function. Remarkably, the microenvironmental change and the functional decline of mid-old cells could be reversed by a young cell-originated protein, SLIT2. Our data identify functional reversion of mid-old cells as a potential method to prevent or ameliorate aspects of aging-related tissue dysfunction.
- 10 November 2023
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 252, 108560
What matters in aging is signaling for responsiveness
- 10 November 2023
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 252, 108560
What matters in aging is signaling for responsiveness
- Open Access
- 20 May 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (11) , 2295-2310.e17
ANT2 Accelerates Cutaneous Wound Healing in Aged Skin by Regulating Energy Homeostasis and Inflammation
- 20 May 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (11) , 2295-2310.e17
Open AccessANT2 Accelerates Cutaneous Wound Healing in Aged Skin by Regulating Energy Homeostasis and Inflammation
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (33) , e258
Epigenetic Regulation of the Expression of T Cell Stimulatory and Inhibitory Factors by Histone H3 Lysine Modification Enzymes and Its Prognostic Roles in Glioblastoma
Lee SH, et al. J Korean Med Sci. 2023 Aug;38(33):e258. https://doi.org/10.3346/jkms.2023.38.e258
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (33) , e258
Open AccessEpigenetic Regulation of the Expression of T Cell Stimulatory and Inhibitory Factors by Histone H3 Lysine Modification Enzymes and Its Prognostic Roles in Glioblastoma
Lee SH, et al. J Korean Med Sci. 2023 Aug;38(33):e258. https://doi.org/10.3346/jkms.2023.38.e258
- Open Access
- 2 September 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (9) , 1-12
Nintedanib induces senolytic effect via STAT3 inhibition
Selective removal of senescent cells, or senolytic therapy, has been proposed to be a potent strategy for overcoming age-related diseases and even for reversing aging. We found that nintedanib, a tyrosine kinase inhibitor, selectively induced the death of primary human dermal fibroblasts undergoing RS. Similar to ABT263, a well-known senolytic agent, nintedanib triggered intrinsic apoptosis in senescent cells. Additionally, at the concentration producing the senolytic effect, nintedanib arrested the cell cycle of nonsenescent cells in the G1 phase without inducing cytotoxicity. Interestingly, the mechanism by which nintedanib activated caspase-9 in the intrinsic apoptotic pathway differed from that of ABT263 apoptosis induction; specifically, nintedanib did not decrease the levels of Bcl-2 family proteins in senescent cells. Moreover, nintedanib suppressed the activation of the JAK2/STAT3 pathway, which caused the drug-induced death of senescent cells. STAT3 knockdown in senescent cells induced caspase activation. Moreover, nintedanib reduced the number of senescence-associated β-galactosidase-positive senescent cells in parallel with a reduction in STAT3 phosphorylation and ameliorated collagen deposition in a mouse model of bleomycin-induced lung fibrosis. Consistently, nintedanib exhibited a senolytic effect through bleomycin-induced senescence of human pulmonary fibroblasts. Overall, we found that nintedanib can be used as a new senolytic agent and that inhibiting STAT3 may be an approach for inducing the selective death of senescent cells. Our findings pave the way for expanding the senolytic toolkit for use in various aging statuses and age-related diseases.
- 2 September 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (9) , 1-12
Open AccessNintedanib induces senolytic effect via STAT3 inhibition
Selective removal of senescent cells, or senolytic therapy, has been proposed to be a potent strategy for overcoming age-related diseases and even for reversing aging. We found that nintedanib, a tyrosine kinase inhibitor, selectively induced the death of primary human dermal fibroblasts undergoing RS. Similar to ABT263, a well-known senolytic agent, nintedanib triggered intrinsic apoptosis in senescent cells. Additionally, at the concentration producing the senolytic effect, nintedanib arrested the cell cycle of nonsenescent cells in the G1 phase without inducing cytotoxicity. Interestingly, the mechanism by which nintedanib activated caspase-9 in the intrinsic apoptotic pathway differed from that of ABT263 apoptosis induction; specifically, nintedanib did not decrease the levels of Bcl-2 family proteins in senescent cells. Moreover, nintedanib suppressed the activation of the JAK2/STAT3 pathway, which caused the drug-induced death of senescent cells. STAT3 knockdown in senescent cells induced caspase activation. Moreover, nintedanib reduced the number of senescence-associated β-galactosidase-positive senescent cells in parallel with a reduction in STAT3 phosphorylation and ameliorated collagen deposition in a mouse model of bleomycin-induced lung fibrosis. Consistently, nintedanib exhibited a senolytic effect through bleomycin-induced senescence of human pulmonary fibroblasts. Overall, we found that nintedanib can be used as a new senolytic agent and that inhibiting STAT3 may be an approach for inducing the selective death of senescent cells. Our findings pave the way for expanding the senolytic toolkit for use in various aging statuses and age-related diseases.